ClinicalTrials.gg
RecruitingNCT06180811Updated May 6, 2024

Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women

An interventional study of Women's Health Delaware Food Farmacy and Usual Standard of Care in Pre-Eclampsia, Obesity and Gestational Diabetes, sponsored by Christiana Care Health Services. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-06.

Sponsored by Christiana Care Health Services · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. The pilot study has three specific aims:

Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed

Aim 2: To determine the prevalence of and change in social needs

Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care

Read the detailed description

This study is a pilot randomized controlled trial where eligible pregnant ChristianaCare patients will be identified weekly through an automated list, and patients who consent will be randomized to 1 of 2 arms (Women's Health Delaware Food Farmacy vs. usual standard of care). Participants randomized to the Women's Health Delaware Food Farmacy program arm will receive medically tailored groceries that are high in micronutrients critical for a healthy pregnancy. The food provided will be the equivalent of 10 meals per person in the household per week and will be delivered to participants weekly from enrollment to 4 weeks after giving birth. Participants will receive culinary equipment and training, recipes, and educational nutrition videos and will interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Participants randomized to the usual standard of care arm will continue to receive their standard of care management.

All participants will complete a questionnaire with patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) at baseline and postpartum and a patient experience survey postpartum related to their experiences receiving prenatal care and giving birth at ChristianaCare. In addition, maternal and child health, healthcare utilization, and clinical event outcomes will be documented for all participants via electronic health records and assessed retrospectively. Quantitative indicators related to feasibility (i.e., acceptability, demand, and implementation) will be collected such as program satisfaction, program enrollment and retention, meals provided to participants and their household, food consumption, and interactions with assigned Community Health Worker.

Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed

H1. Primary outcomes. The investigators hypothesize that the Women's Health Delaware Food Farmacy will: (a) prove acceptable to participants, as measured by program satisfaction; (b) meet demand, as measured by project recruitment and retention, number of meals provided to participants and their household, and number of people providing food for; and (c) prove implementable, as measured by food consumption, number of Community Health Worker interactions, number of educational videos watched, number of recipes reviewed, and number of meal preparation sessions.

Aim 2: To determine the prevalence of and change in social needs

H2. Primary outcome. Social needs will be identified by administering the ChristianaCare Social Determinants of Health Screener and resource referrals will be sent on participants' behalf to support their social needs, both of which are the usual standard of care. The investigators hypothesize that social needs will be identified through the ChristianaCare Social Determinants of Health Screener, and that compared to baseline, participants at postpartum will experience reductions in their social needs. The investigators also hypothesize there will be some participants whose social needs will not be resolved due to a lack of community resources.

Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care

H3a. Primary outcomes. Maternal and child health outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in maternal and child health outcomes (e.g., preeclampsia and small for gestational age) from baseline to postpartum.

H3b. Primary outcomes. Maternal and child healthcare utilization outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child healthcare utilization outcomes (e.g., neonatal intensive care unit [NICU] admission and maternal length of stay) from baseline to postpartum.

H3c. Primary outcomes. Maternal and child clinical event outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child clinical event outcomes (e.g., cesarean delivery and fetal death) from baseline to postpartum.

H3d. Secondary outcomes. Patient-reported outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) from baseline to postpartum.

02

Conditions studied

  • Pre-Eclampsia
  • Obesity
  • Gestational Diabetes
  • Gestational Hypertension

Keywords

  • Food is Medicine
  • Community Health Worker
  • Social Needs
  • Medically Tailored Groceries
  • Randomized Controlled Trial
  • Maternal and Child Health
03

In context

Pre-Eclampsia

916 studies on the registry are indexed under Pre-Eclampsia; 243 are open to participants now.

This study's planned enrollment of 250 is above the median of 110 across 480 interventional studies indexed under Pre-Eclampsia.

Browse Pre-Eclampsia studies →

Lead sponsor

Christiana Care Health Services is the lead sponsor of 94 studies on the registry; 6 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ChristianaCare Women's Health patient
  • 18 years or older
  • 4 to 14 weeks pregnant
  • Singleton pregnancy
  • Medicaid
  • of 30 or higher
  • Reside in New Castle County

Exclusion criteria

Exclusion Criteria:

  • Current diagnosis of type 1 or type 2 diabetes
  • Multiple pregnancy
  • Currently enrolled in another Community Health Worker program
  • Not able to store and prepare meals
  • Diagnosed with severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization
  • Not able to understand and communicate effectively in English or Spanish
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Women's Health Delaware Food Farmacy

    Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.

    Other: Women's Health Delaware Food Farmacy

  • Active comparator
    Usual Standard of Care

    Participants will receive the usual standard of care.

    Other: Usual Standard of Care

Interventions

  • OtherWomen's Health Delaware Food Farmacy

    Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.

  • OtherUsual Standard of Care

    Participants will receive the usual standard of care.

06

What researchers measure

Primary outcomes

  1. Social Determinants of Health

    Measured with ChristianaCare Social Determinants of Health Screener; Number of socials needs range from 0-11, higher scores indicate greater number of social needs

    Time frame: Changes from baseline to 2-6 weeks after delivery

  2. Gestational Weight Gain

    Observed gestational weight gained

    Time frame: Changes from baseline to 2-6 weeks after delivery

  3. Body Mass Index

    Observed body mass index changes

    Time frame: Changes from baseline to 2-6 weeks after delivery

  4. Gestational Diabetes

    Occurrence of gestational diabetes

    Time frame: From baseline to delivery

  5. Gestational Hypertension

    Occurrence of gestational hypertension

    Time frame: From baseline to delivery

  6. Systolic and Diastolic Blood Pressure

    Observed systolic and diastolic blood pressure

    Time frame: Changes from baseline to 2-6 weeks after delivery

  7. Preeclampsia

    Occurrence of preeclampsia and week diagnosed during pregnancy

    Time frame: From baseline to 2-6 weeks after delivery

  8. Hydramnios

    Occurrence of hydramnios

    Time frame: From baseline to delivery

  9. Gestational Age

    Baby's gestational age at birth

    Time frame: At delivery

  10. Small for Gestational Age

    Birth weight less than 10th percentile based on gestational age

    Time frame: At delivery

  11. Preterm Birth

    Preterm birth less than 37 weeks

    Time frame: At delivery

  12. Fetal Macrosomia

    Birth weight greater than 90th percentile based on gestational age

    Time frame: At delivery

  13. Cesarean Delivery

    Occurrence of cesarean delivery including those planned and unplanned

    Time frame: At delivery

  14. Fetal Death

    Occurrence of fetal death

    Time frame: From baseline to delivery

  15. NICU Admission

    Occurrence of NICU admission for any reason

    Time frame: Within 48 hours after delivery

  16. NICU Length of Stay

    Number of days baby was admitted to NICU

    Time frame: From NICU admission date to NICU discharge date, assessed up to 90 days

  17. Maternal Length of Stay

    Number of days hospitalized following delivery

    Time frame: From delivery date to hospital discharge date, assessed up to 90 days

  18. Postpartum Admission

    Number of postpartum hospital admissions for any reason

    Time frame: From delivery discharge to 90 days after

  19. Postpartum Admission Length of Stay

    Number of days hospitalized

    Time frame: From postpartum admission date to hospital discharge date, assessed up to 90 days

  20. Hospital Admission

    Number of hospital admissions for any reason

    Time frame: From baseline up to delivery

  21. Hospital Admission Length of Stay

    Number of days hospitalized

    Time frame: From admission date to hospital discharge date, assessed up to 90 days

  22. Emergency Room Visit

    Number of emergency room visits for any reason

    Time frame: From baseline to 90 days after delivery

Secondary outcomes

  1. Food Insecurity

    Measured with United States Department of Agriculture Household Food Security Survey Module 6-Item Short Form, 30-day; Scores range from 0-6, higher scores indicate lower food security

    Time frame: Changes from baseline to 2-6 weeks after delivery

  2. Dietary Intake

    Measured with Dietary Screener Questionnaire (DSQ-10) and six items from Dietary Screener Questionnaire (DSQ-26); Scores will be calculated using the National Cancer Institute's scoring algorithms

    Time frame: Changes from baseline to 2-6 weeks after delivery

  3. Health-Related Quality of Life

    Measured with Centers for Disease Control and Prevention's Health-Related Quality of Life (HRQOL-4) scale; Number of healthy days range from 0-30, higher scores indicate greater number of healthy days

    Time frame: Changes from baseline to 2-6 weeks after delivery

  4. Cost-Related Medication Underuse

    Measured with Cost-Related Medication Underuse; Scores range from 0-4, scores greater than 0 indicate cost-related medication underuse

    Time frame: Changes from baseline to 2-6 weeks after delivery

07

Study locations

1 of 1 sites recruiting
  • ChristianaCare Christiana Hospital
    Newark, Delaware 19718, United States
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06180811
Lead sponsor
Christiana Care Health Services
Responsible party
Sponsor
First posted
Dec 26, 2023
Start date
Jan 2, 2024
Primary completion
Nov 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
May 6, 2024

Study contacts

Kathleen McCallops, PhD
Contact
kathleen.mccallops@christianacare.org
3024286590
Michelle Axe, MS, CHES
Contact
michelle.axe@christianacare.org
3024286590

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion